Sy Mukherjee

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

128 pages

Health The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
BYSy Mukherjee and IDEA Pharma
April 20, 2022
Newsletters The science behind a fond farewell
BYSy Mukherjee
September 23, 2021
Health Health insurers justify passing COVID treatment costs on to patients despite massive profits
BYSy Mukherjee
September 23, 2021
Health What comes next for COVID booster shots after the FDA panel hedges on Pfizer
BYSy Mukherjee
September 17, 2021
Newsletters The failed bid to topple Gavin Newsom and the politics of public health
BYSy Mukherjee
September 16, 2021
Health 3 things you should know about the timeline for kids’ COVID vaccines
BYSy Mukherjee
September 16, 2021

Newsletters 20 years after 9/11, first responders are still sick, dying, and underpaid
BYSy Mukherjee
September 9, 2021
Health Parkinson’s disease has no approved treatment. Scientists want to use lab grown mini-brains to change that
BYSy Mukherjee
September 8, 2021
Newsletters There have been 154 retracted COVID studies. The damage may already be done
BYSy Mukherjee
September 2, 2021
Health The psychology behind why people will take horse paste, but not COVID vaccines
BYSy Mukherjee
September 2, 2021
Health 1 in 3 Americans had COVID in 2020, according to new research
BYSy Mukherjee
August 27, 2021
Newsletters Google Health is being dismantled, but Big Tech’s quixotic health ambitions persist
BYSy Mukherjee
August 26, 2021
Health Booster shots for Johnson & Johnson COVID vaccines could be coming soon
BYSy Mukherjee
August 25, 2021
Health Why it’s taking so long to get COVID vaccines for kids under 12
BYSy Mukherjee
August 25, 2021
Health What Pfizer’s FDA approval means for Americans and businesses
BYSy Mukherjee
August 24, 2021

1 - 15 of 1919 results

...